People with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.

by Kendall K. Morgan

Blood tests can guide treatment choices, delivering results in less time than traditional biopsies.

by Stephen Ornes

Rural residents with cancer tend to have later diagnoses and poorer outcomes. Researchers and oncologists are working to identify and remove the barriers they face.

by Mark Ray

Facts and Stats

People diagnosed with cancer can participate in various kinds of studies.

by Thomas Celona

FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.

by Sandra Gordon

Reports on breast density inform women of their status but raise questions about what to do next.

by Robin Roenker

Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.

by Laura Gesualdi-Gilmore

A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.

by Sandra Gordon

New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.

by Laura Gesualdi-Gilmore

Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.

by Kyle Bagenstose